Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 766 AL 780

Advanced glycation end-products produced systemically and by macrophages: A common contributor to inflammation and degenerative diseases

Byun K, Yoo Y, Son M, Lee J, Jeong GB, Park YM, Salekdeh GH, Lee B.

Pharmacol Ther. 2017 Sep;177:44-55. doi: 10.1016/j.pharmthera.2017.02.030. Epub 2017 Feb 13.

Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson's disease - a randomized controlled trial

Schreglmann SR, Büchele F, Sommerauer M, Epprecht L, Kägi G, Hägele-Link S, Götze O, Zimmerli L, Waldvogel D, Baumann CR.

Eur J Neurol. 2017 Apr;24(4):545-551. doi: 10.1111/ene.13260. Epub 2017 Feb 22.

[Multiple sclerosis - a mitochondria-mediated disease?]

Varhaug KN, Vedeler CA, Tzoulis C, Bindoff LA.

Tidsskr Nor Laegeforen. 2017 Feb 21;137(4):284-287. doi: 10.4045/tidsskr.16.0210. eCollection 2017 Feb.

Current Concepts on the Physiopathological Relevance of Dopaminergic Receptors

Ledonne A, Mercuri NB.

Front Cell Neurosci. 2017 Feb 8;11:27. doi: 10.3389/fncel.2017.00027. eCollection 2017.

[Rapidly progressive dementia and parkinsonism associated to multiple dural arteriovenous fistulas]

Mejia P, Piedra LM, Merchan-Del Hierro X.

Rev Neurol. 2017 Mar 1;64(5):214-218.

Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update

Voon V, Napier TC, Frank MJ, Sgambato-Faure V, Grace AA, Rodriguez-Oroz M, Obeso J, Bezard E, Fernagut PO.

Lancet Neurol. 2017 Mar;16(3):238-250. doi: 10.1016/S1474-4422(17)30004-2. Epub 2017 Feb 15.

MtDNA meta-analysis reveals both phenotype specificity and allele heterogeneity: a model for differential association

Marom S, Friger M, Mishmar D.

Sci Rep. 2017 Feb 23;7:43449. doi: 10.1038/srep43449.

Dissection of Regulatory Elements During Direct Conversion of Somatic Cells Into Neurons

Soleimani T, Falsafi N, Fallahi H.

J Cell Biochem. 2017 Oct;118(10):3158-3170. doi: 10.1002/jcb.25944. Epub 2017 Jun 7.

Update on the 22q11.2 deletion syndrome and its relevance to schizophrenia

Van L, Boot E, Bassett AS.

Curr Opin Psychiatry. 2017 May;30(3):191-196. doi: 10.1097/YCO.0000000000000324.

The Complicated Relationship between Gaucher Disease and Parkinsonism: Insights from a Rare Disease

Aflaki E, Westbroek W, Sidransky E.

Neuron. 2017 Feb 22;93(4):737-746. doi: 10.1016/j.neuron.2017.01.018.

Targets and Mechanisms in Prevention of Parkinson's Disease through Immunomodulatory Treatments

von Euler Chelpin M, Vorup-Jensen T.

Scand J Immunol. 2017 May;85(5):321-330. doi: 10.1111/sji.12542.

Yeast models of Parkinson's disease-associated molecular pathologies

Tenreiro S, Franssens V, Winderickx J, Outeiro TF.

Curr Opin Genet Dev. 2017 Jun;44:74-83. doi: 10.1016/j.gde.2017.01.013.

Leber Hereditary Optic Neuropathy: Exemplar of an mtDNA Disease

Wallace DC, Lott MT.

Handb Exp Pharmacol. 2017;240:339-376. doi: 10.1007/164_2017_2.

Upper camptocormia in Parkinson's disease reversed by bilateral subthalamic deep brain stimulation

Pandey S.

Parkinsonism Relat Disord. 2017 Apr;37:123-124. doi: 10.1016/j.parkreldis.2017.02.013. Epub 2017 Feb 20.

Maladie de Parkinson et syndromes parkinsoniens : les signes moteurs

Grabli D.

Presse Med. 2017 Mar;46(2 Pt 1):187-194. doi: 10.1016/j.lpm.2017.01.003. Epub 2017 Feb 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias